Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FABOLUS: Abciximab Bolus Only vs Bolus + Infusion in NSTEACS
NCT00929279Phase 4Completed
- Sponsor
- University of Ferrara
- Start
- Nov 2008
- Primary completion
- May 2009
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of abciximab in acute coronary syndrome (ACS), sponsored by University of Ferrara. Started Nov 2008; status: completed.
02
Drugs
abciximab
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00929279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00929279.